# reload+after+2024-01-21 06:45:06.649908
address1§2223 Avenida de la Playa
address2§Suite 208
city§LA Jolla
state§CA
zip§92037
country§United States
phone§619 400 1170
website§https://www.gribio.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.
fullTimeEmployees§1
companyOfficers§[{'maxAge': 1, 'name': 'Dr. W. Marc Hertz Ph.D.', 'age': 53, 'title': 'Co-Founder, CEO, President & Director', 'yearBorn': 1970, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Vipin  Kumar Chaturvedi Ph.D.', 'age': 64, 'title': 'Co-Founder & Chief Scientific Officer', 'yearBorn': 1959, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Leanne M. Kelly', 'age': 46, 'title': 'CFO & Corporate Secretary', 'yearBorn': 1977, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Albert  Agro Ph.d.', 'age': 58, 'title': 'Chief Medical Officer', 'yearBorn': 1965, 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§4
payoutRatio§0.0
currency§USD
dateShortInterest§1702598400
exchange§NCM
quoteType§EQUITY
shortName§GRI Bio, Inc.
longName§GRI Bio, Inc.
firstTradeDateEpochUtc§1612967400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§2a4b9e2e-4254-393c-ba83-44e16bef237a
gmtOffSetMilliseconds§-18000000
recommendationMean§2.0
recommendationKey§buy
quickRatio§1.602
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
